Gacang, Kate .

HRN: 28-36-89  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/06/2026
CEFUROXIME 750MG (VIAL)
01/06/2026
01/12/2026
IV
750mg
Q8
UTI
Waiting Final Action 
01/07/2026
MEBENDAZOLE 100MG/5ML, 60ML SUSPENSION
01/07/2026
01/10/2026
ORAL
5ml
BID
Intestinal Parasitic Infection
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: